TNA
PFE icon

True North Advisors’s Pfizer PFE Stock Holding History

True North Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
49,122
+1,804
+4% +$47.2K 0.11% 107
2026
Q1 		$1.33M Sell
47,318
-6,296
-12% -$168K 0.15% 94
2025
Q4 		$1.33M Sell
53,614
-10,380
-16% -$262K 0.17% 90
2025
Q3 		$1.63M Buy
63,994
+9,278
+17% +$229K 0.26% 62
2025
Q2 		$1.33M Sell
54,716
-2,139
-4% -$49.9K 0.25% 76
2025
Q1 		$1.44M Buy
56,855
+4,267
+8% +$112K 0.26% 81
2024
Q4 		$1.4M Buy
52,588
+666
+1% +$18.1K 0.33% 52
2024
Q3 		$1.5M Sell
51,922
-1,461
-3% -$42.6K 0.39% 42
2024
Q2 		$1.49M Buy
53,383
+510
+1% +$14K 0.4% 38
2024
Q1 		$1.47M Sell
52,873
-1,129
-2% -$31.3K 0.41% 40
2023
Q4 		$1.55M Buy
54,002
+423
+0.8% +$12.8K 0.4% 41
2023
Q3 		$1.78M Sell
53,579
-592
-1% -$20.9K 0.55% 34
2023
Q2 		$1.99M Sell
54,171
-22,690
-30% -$883K 0.56% 39
2023
Q1 		$3.14M Sell
76,861
-5,752
-7% -$248K 0.92% 19
2022
Q4 		$4.23M Buy
82,613
+781
+1% +$37.4K 1.44% 13
2022
Q3 		$3.58M Sell
81,832
-469
-0.6% -$22.8K 1.17% 14
2022
Q2 		$4.32M Buy
82,301
+115
+0.1% +$5.86K 1.34% 12
2022
Q1 		$4.25M Sell
82,186
-2,004
-2% -$104K 1.14% 14
2021
Q4 		$4.97M Buy
84,190
+5,529
+7% +$274K 0.84% 21
2021
Q3 		$3.38M Buy
78,661
+2,432
+3% +$108K 0.67% 32
2021
Q2 		$2.98M Sell
76,229
-591
-0.8% -$23K 0.62% 36
2021
Q1 		$2.78M Buy
76,820
+126
+0.2% +$4.47K 0.66% 33
2020
Q4 		$2.82M Sell
76,694
-12,881
-14% -$472K 0.72% 34
2020
Q3 		$3.12M Buy
89,575
+2,567
+3% +$90K 0.91% 27
2020
Q2 		$2.7M Buy
87,008
+12,926
+17% +$439K 0.65% 35
2020
Q1 		$2.29M Buy
74,082
+1,072
+1% +$36.5K 0.78% 32
2019
Q4 		$2.71M Buy
+73,010
New +$2.6M 0.76% 36

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

True North Advisors's PFE Position: Q2 2026 in Review

True North Advisors increased its Pfizer (PFE) stake by 3.8% in Q2 2026, buying an estimated $47.2K and bringing the position to 49,122 shares worth $1.18M. The position accounts for 0.11% of the portfolio, ranked #107.

True North Advisors first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $4.97M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • True North Advisors held 49,122 shares of Pfizer worth $1.18M as of Q2 2026.
  • True North Advisors bought 1,804 Pfizer shares in Q2 2026, an estimated $47.2K.
  • Pfizer made up 0.11% of True North Advisors's portfolio in Q2 2026, its #107 holding.
  • True North Advisors first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • True North Advisors's Pfizer position peaked at $4.97M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on True North Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.